Precipio Signs Distribution Agreement For IV-Cell® and HemeScreen® in Japan
January 17, 2024 10:30 ET
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 17, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces it has entered into an agreement with a Japanese distributor for the...
Celsion Reports T-cell and B-cell Response from In Vivo Studies with its PLACCINE DNA Vaccine Platform
September 02, 2021 08:00 ET
|
Celsion CORP
Results Indicate Induction of Adaptive Immune Response Against SARS-CoV-2 Company Plans Additional Development Work to Further Optimize its Vaccine Platform Through Vector Compositions, Delivery...
Aldevron Now Utilizing Berkeley Lights' Beacon® Platform
June 11, 2019 07:02 ET
|
Aldevron
Fargo, N.D., June 11, 2019 (GLOBE NEWSWIRE) -- Aldevron, a global leader in antibody discovery to the biotech industry, announced today the acquisition and installation of the Beacon Optofluidic...
Aldevron Now Utilizing Berkeley Lights' Beacon® Platform
June 11, 2019 00:02 ET
|
Aldevron
Fargo, N.D., June 11, 2019 (GLOBE NEWSWIRE) -- Aldevron, a global leader in antibody discovery to the biotech industry, announced today the acquisition and installation of the Beacon Optofluidic...